Gary Clark: Unfiltered

The packaging giant pushed its debt wall to 2030 and stripped key covenants. We analyze the strategic brilliance and the high-stakes bargain for investors.

The REIT's strategic land sale accelerates its deleveraging, but the deal's true impact lies in its transformation and the future of Jersey City's skyline.

BridgeBio Oncology's new drug candidate BBO-10203 could redefine cancer therapy by avoiding a key toxicity, unlocking a vast market.

Fintech firm Nayax's oversubscribed Israeli offering signals strong investor confidence and fuels its ambitious plan for global expansion through acquisitions.

A small biotech is challenging oncology's giants with a drug that targets cancer's core weakness, offering new hope to the sickest lung cancer patients.

Micro-cap BSEG racks up awards against giants like Variety, but with a volatile stock and weak fundamentals, can creative success spark a financial turnaround?

Borr Drilling leverages complex debt and equity financing to acquire five premium rigs, a high-stakes bet on a strengthening offshore drilling market.

A V2G pioneer pivots its intelligent software to compete for a massive national energy storage contract in South Korea's booming, high-stakes market.

Daré Bioscience is targeting a 20M-woman market with a novel arousal cream. This is the story of its clever regulatory strategy and high-stakes bet.

Beyond webinars, ON24's G2 win and LinkedIn pact reveal a strategic shift to AI-driven data and connected campaigns in the B2B marketing tech war.

Quantum Computing Inc. is leaving the lab for Las Vegas, betting its US-made photonic chips can solve real-world AI problems and justify a lofty valuation.

A Hong Kong award for Youxin Technology offers a deeper look into the firm's strategic acquisition, its role in the GBA, and what it means for investors.

Promising data for NuCana's NUC-7738 offers hope for tough-to-treat melanoma, but the biotech's financial health presents a critical hurdle.

The space firm secures vital cash through a complex warrant deal, but at what cost to shareholders? All eyes are now on a critical investor vote.

A new partnership signals a shift towards versatile, American-made drone systems, streamlining critical missions and challenging market incumbents.

With extensive mineralization confirmed and $6M in fresh capital, SAGA Metals' Radar Project is rapidly de-risking a major critical minerals discovery.

Brightstar Lottery's expansion into Pennsylvania with its Cash Pop game and a new $20 price point isn't just a launch—it's a calculated bet on a new player.

Following stellar clinical data, Terns Pharmaceuticals' upsized $650M offering signals massive investor confidence and funds its push to disrupt the CML market.

Beyond the gas pump, Casey's is winning with a savvy M&A strategy and a food service empire that rivals fast-food chains. Here’s what it means.

Beyond a simple payout, Qnity Electronics' increased dividend reveals its deep financial strength and strategic position fueling the AI and HPC revolution.